Literature DB >> 22713164

Serum and peritoneal fluid immunological markers in adolescent girls with chronic pelvic pain.

Agnieszka Drosdzol-Cop1, Violetta Skrzypulec-Plinta, Rafał Stojko.   

Abstract

The aim of this study was to determine serum and peritoneal interleukin (IL)-2, IL-4, and monocyte chemotactic protein-1 levels as diagnostic markers of endometriosis in adolescent girls. The design of the study encompassed 50 adolescent girls, aged 13 to 19 years after menarche, with chronic pelvic pain who qualified for diagnostic laparoscopy. The patients were allocated into 2 groups: group I (endometriosis) consisted of subjects with diagnosed endometriosis (n = 33, 66%) and group II (control) whose laparoscopic examinations revealed no evidence of endometriosis (n = 17, 34%). IL-2, IL-4, and Monocyte chemotactic protein 1 concentrations in serum and peritoneal samples were assessed using commercially available human enzyme-linked immunosorbent assay kits. The results were analyzed statistically with the Statistica 8.0 computer software. The value of P < 0.05 was the level of statistical significance. The results in adolescents with endometriosis had significantly higher concentrations of serum IL-4 (3.90 ± 1.58 pg/mL vs. 3.04 ± 1.72 pg/mL; P = 0.04) and peritoneal fluid IL-4 (5.03 ± 8.92 pg/mL vs. 2.74 ± 1.11 pg/mL; P = 0.03), and lower peritoneal fluid IL-2 (92.44 ± 292.75 pg/mL vs. 174.23 ± 389.77 pg/mL; P = 0.01) compared with the control. In a receiver-operating characteristic analysis, serum IL-4 as well as peritoneal fluid IL-2 and IL-4 provided the best discriminative ability between subjects with endometriosis and controls. Using cutoff points for serum IL-4 (3.00 pg/mL), peritoneal fluid IL-2 (21.00 pg/mL) and IL-4 (2.7 pg/mL), relatively high odd ratios were obtained in the prediction of endometriosis in adolescents (3.2; 6.4; 3.3). The Serum IL-4, peritoneal IL-2 and IL-4 provided a good method of discrimination between subjects with endometriosis and controls.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713164     DOI: 10.1097/OGX.0b013e31825cb12b

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  9 in total

Review 1.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

Review 2.  Endometriosis: New Perspective for the Diagnosis of Certain Cytokines in Women and Adolescent Girls, as Well as the Progression of Disease Outgrowth: A Systematic Review.

Authors:  Jakub Toczek; Żaneta Jastrzębska-Stojko; Rafał Stojko; Agnieszka Drosdzol-Cop
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

3.  Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.

Authors:  Aitana Braza-Boïls; Juan Gilabert-Estellés; Luis A Ramón; Juan Gilabert; Josep Marí-Alexandre; Melitina Chirivella; Francisco España; Amparo Estellés
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis.

Authors:  Andrei Mihai Măluţan; Tudor Drugan; Răzvan Ciortea; Radu Florin Mocan-Hognogi; Carmen Bucuri; Maria Patricia Rada; Dan Mihu
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

5.  The association between interleukin-4 -590C/T genetic polymorphism, IL-4 serum level, and advanced endometriosis.

Authors:  Andrei M Malutan; Cristina Drugan; Tudor Drugan; Razvan Ciortea; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

6.  Analysis of menstrual effluent: diagnostic potential for endometriosis.

Authors:  Laura A Warren; Andrew Shih; Susana Marquez Renteira; Tamer Seckin; Brandon Blau; Kim Simpfendorfer; Annette Lee; Christine N Metz; Peter K Gregersen
Journal:  Mol Med       Date:  2018-03-19       Impact factor: 6.354

7.  Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls.

Authors:  Sahel Heidari; Roya Kolahdouz-Mohammadi; Sepideh Khodaverdi; Nader Tajik; Ali-Akbar Delbandi
Journal:  BMC Womens Health       Date:  2021-12-20       Impact factor: 2.809

8.  Chronic pelvic pain in endometriosis: an overview.

Authors:  Onofrio Triolo; Antonio Simone Laganà; Emanuele Sturlese
Journal:  J Clin Med Res       Date:  2013-04-23

Review 9.  Update on Biomarkers for the Detection of Endometriosis.

Authors:  Amelie Fassbender; Richard O Burney; Dorien F O; Thomas D'Hooghe; Linda Giudice
Journal:  Biomed Res Int       Date:  2015-07-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.